Management of cancer treatment-induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey
CONCLUSION: A heterogeneous approach on the management of cancer treatment-induced bone loss in Italy arises from this survey. This scenario highlights the need for a major consensus of the Italian scientific community on the diagnostic and therapeutic approach of cancer treatment-induced bone loss and for a greater awareness of this topic among Italian oncologists.PMID:38462772 | DOI:10.1177/03008916241236279
Source: Tumori - Category: Cancer & Oncology Authors: Anna Amela Valsecchi Vittorio Fusco Massimo Di Maio Daniele Santini Marcello Tucci Ugo De Giorgi Rossana Dionisio Francesca Vignani Saverio Cinieri Source Type: research
More News: Breast Cancer | Cancer | Cancer & Oncology | DEXA Scan | Hormonal Therapy | Hormones | Italy Health | Orthopaedics | Prostate Cancer